NYSE : WST
West Pharmaceutical Services, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 412.62 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 28.74B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 28.85B |
| Enterprise Value | 28.70B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Nov 10, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 69.66M |
| Shares Outstanding | 69.66M |
| Shares Change (YoY) | -1.48% |
| Shares Change (QoQ) | -0.70% |
| Owned by Insiders (%) | 0.64% |
| Owned by Institutions (%) | 103.06% |
| Float | 69.13M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 46.51 |
| Forward PE | 41.50 |
| PS Ratio | 8.46 |
| Forward PS | 8.20 |
| PB Ratio | 9.70 |
| P/TBV Ratio | 10.07 |
| P/FCF Ratio | 63.40 |
| P/OCF Ratio | 43.92 |
| PEG Ratio | 2.69 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 44.75 |
| EV / Sales | 8.42 |
| EV / EBITDA | 29.74 |
| EV / EBIT | 36.80 |
| EV / FCF | 63.06 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 2.82 |
| Quick Ratio | 1.91 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.31 |
| Debt / FCF | 0.69 |
| Interest Coverage | 95.93 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 21.23% |
| Return on Assets (ROA) | 11.89% |
| Return on Invested Capital (ROIC) | 21.62% |
| Return on Capital Employed (ROCE) | 22.74% |
| Weighted Average Cost of Capital (WACC) | 10.42% |
| Revenue Per Employee | $314,509 |
| Profits Per Employee | $59,157 |
| Employee Count | 10,800 |
| Asset Turnover | 0.83 |
| Inventory Turnover | 4.70 |
Taxes
| Measure | Value |
|---|
| Income Tax | 168.20M |
| Effective Tax Rate | 20.84% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.14 |
| 52-Week Price Change | +46.45% |
| 50-Day Moving Average | 368.80 |
| 200-Day Moving Average | 314.05 |
| Relative Strength Index (RSI) | 75.54 |
| Average Volume (20 Days) | 603,023 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.01M |
| Short Previous Month | 2.38M |
| Short % of Shares Out | 2.89% |
| Short % of Float | 2.91% |
| Short Ratio (days to cover) | 3.38 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.40B |
| Gross Profit | 1.28B |
| Operating Income | 777.00M |
| Pretax Income | 807.10M |
| Net Income | 638.90M |
| EBITDA | 961.30M |
| EBIT | 777.00M |
| Earnings Per Share (EPS) | $8.90 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 464.10M |
| Total Debt | 313.90M |
| Net Cash | 150.20M |
| Net Cash Per Share | $2.16 |
| Equity (Book Value) | 2.97B |
| Book Value Per Share | 42.52 |
| Working Capital | 1.17B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 654.50M |
| Capital Expenditures | -201.10M |
| Depreciation & Amortization | 184.30M |
| Net Borrowing | -1.50M |
| Free Cash Flow | 453.40M |
| FCF Per Share | $6.51 |
Margins
| Measure | Value |
|---|
| Gross Margin | 37.59% |
| Operating Margin | 22.88% |
| Pretax Margin | 23.76% |
| Profit Margin | 18.81% |
| EBITDA Margin | 28.30% |
| EBIT Margin | 22.88% |
| FCF Margin | 13.35% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $1.04 |
| Dividend Yield | 0.25% |
| Dividend Growth (YoY) | 8.24% |
| Years of Dividend Growth | 33 |
| Payout Ratio | 10.33% |
| FCF Payout Ratio | 14.14% |
| Buyback Yield | 1.48% |
| Shareholder Yield | 1.73% |
| Earnings Yield | 2.15% |
| FCF Yield | 1.58% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $471.00 |
| Price Target Difference | 13.73% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 16 |
| Revenue Growth Forecast (3Y) | 8.40% |
| EPS Growth Forecast (3Y) | 17.52% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Sep 27, 2013 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 15.05 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |